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Abstract:  
 
Objectives: Sleep duration and disturbances may be risk factors for hypertension. Despite 
the high burden of hypertension in South Asia, little is known about this relationship in 
this region.  
 
Methods: We analyzed population-level cross-sectional data from the Centre for 
Cardiometabolic Risk Reduction in South Asia (CARRS) study that recruited representative 
samples of adults ≥ 20 years from three cities- Delhi, Chennai (India) and Karachi 
(Pakistan) during 2010-11. We defined hypertension as self-reported treatment or 
measured blood pressure (BP) ≥140/90mmHg. Data on usual duration of sleep, insomnia 
and snoring were collected using “The Sleep Habits Questionnaire” and excessive daytime 
sleepiness (EDS) using Epworth Sleepiness Score. Logistic and linear regression were 
done with hypertension and BP as outcome variables, respectively. Age, sex, education, 
wealth index, family history, and body mass index (BMI) were included as covariates. We 
used multiple imputation to account for missing variables. 
 
Results: Prevalence of hypertension was 30.1%. The mean (SD) sleep duration was 7.3 
(1.2) hours. Insomnia, snoring and EDS were present in 13.6%, 28.7% and 4.6%, 
respectively. Moderate and habitual snoring were associated with increased odds of 
hypertension (OR=1.18, 95% CI [1.04, 1.33] and 1.47 [1.29, 1.67], respectively), after 
adjusting for covariates. Rare, occasional and frequent insomnia were associated with 
increased hypertension (OR 1.41, [1.12, 1.77], 1.39 [1.16, 1.67], 1.34 [1.09, 1.65], 
respectively). Sleep duration and EDS were not associated with hypertension.  
 
Conclusion: Self-reported snoring and insomnia were associated with hypertension in 
South Asia.  This relationship needs further exploration through robust longitudinal 
studies in this region. 
 
Keywords: Hypertension, blood pressure, sleep duration, insomnia, snoring, daytime 
sleepiness, South Asia  
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Statement of Significance 
This study addresses the important lacunae in population level sleep and health 
relationship in rapidly developing South Asian Cities. The study found high prevalence 
insomnia and self-reported snoring among adults in urban South Asia. The odds of 
hypertension were 18 and 47% higher for moderate and habitual snorers and 34-41% 
higher among participants with insomnia. Duration of sleep and excessive daytime 
sleepiness were not associated with hypertension.   
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Introduction:  
 
Rapid unplanned urbanization and globalization in South Asia have resulted in adoption of 
lifestyles that includes high consumption of calorie dense foods, low physical activity, and 
psychological stresses leading to overweight and an increased susceptibility to 
hypertension, diabetes, and cardiac diseases.1 Lifestyle changes, stress, and obesity are 
also risk factors for sleep loss and disturbances. 2,3  Urban lifestyles are associated with 
longer commutes to work, more hours spent watching television, and habitual internet use 
which can potentially result in shorter sleep duration and disturbances. Additionally, sleep 
duration4,5 and disturbances are possible risk factors for hypertension.6-8 Insomnia, a 
disorder in which there is difficulty in falling asleep or staying asleep or both, despite 
adequate opportunity to sleep,9 is considered a risk factor for hypertension,10 but  the 
evidence for this is not consistent. 5,6,11,12 Snoring, a symptom of obstructive sleep apnea 
(OSA),13,14 is  identified as an independent risk factor for hypertension.7,15-17 But, there is 
little evidence on independent associations between Excessive daytime sleepiness (EDS), 
another cardinal symptom of OSA, and hypertension.15,18 
 
In South Asia, population data on usual duration and disturbances of sleep (insomnia, 
snoring, and EDS) are limited.19,20 Nearly one third of the adult populations in countries 
like India and Pakistan are estimated to have hypertension.21-23 Despite this high burden, 
the relationship of hypertension with sleep-duration and sleep-disturbances have 
remained largely unexplored.  To address this gap, we examined potential associations 
between sleep parameters and hypertension by analyzing data from a cross-sectional 
representative survey of 16287 adults aged ≥20 years in three mega-cities (Chennai, Delhi 
and Karachi) of South Asia. 
  
Methods: 
 
We used data from the baseline survey of the Centre for Cardiometabolic Risk Reduction 
in South Asia (CARRS) study collected during 2010-11.24  The methods, participant 
recruitment, data collection in CARRS cohort study are published in detail elsewhere 24 
Briefly, participants were recruited by multi-stage cluster random sampling technique 
stratified by gender and city of residence. Primary sampling units(PSUs) were wards or 
larger municipal subdivisions for Delhi and Chennai respectively while, clusters were the 
PSUs for Karachi. At the time of data collection, the most recent census in each country 
(India-2001 census; Pakistan 1998 census) was used to randomly select the wards, 
clusters, or census enumeration blocks (CEB- smallest municipal subdivision in Indian 
cities), and households. In order to account for changes that may have happened in the 
interim, we manually listed and mapped all households in each CEB before randomly 
selecting them.24,25 The “Kish Method”,  used in the WHO’s STEPS surveys,26 was used to 
select two participants (one male and one female), aged 20 years or older from each 
household. Pregnant women, bed-ridden individuals and persons unable to understand 
the questionnaire due to severe mental illness were excluded. Response rates were 94·7% 
for questionnaire completion and 84·3% for bio-specimens.25  
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Data were collected through personal interviews at the participants’ homes using 
structured questionnaires. Blood pressure was measured twice at participants’ homes by 
trained study staff using an electronic sphygmomanometer (Omron Dailan Co., Ltd, Dalian, 
Liaoning, China) in a seated position with a five-minute gap between measurements. A 
third measurement was obtained if the difference between the first two systolic (SBP) or 
diastolic (DBP) measurements was more than 10 mmHg or 5 mmHg, respectively.  The 
time of blood pressure measurement varied between participants and was usually 
between 7am to 4pm.  The mean of the first two BP measurements, or the second and 
third measurements if a third measurement was taken, were used for analyses. Participant 
was classified as having hypertension if SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg or self-
reported hypertension medication.27  
 
Data on sleep habits were collected using “The Sleep Habits Questionnaire” to assess usual 
sleep habits and sleep disorders including insomnia and snoring; this questionnaire has 
been used previously in Sleep Heart Health Study (SHHS).28  The Epworth sleepiness 
scores (ESS) 29,30 was used to measure daytime sleepiness. The English questionnaires 
were translated to local languages (Tamil, Hindi and Urdu) and back translated to English.  
The questionnaires were piloted and interviewer debriefing method was used assess any 
difficulty or variation in understanding of the items in the questions and wordings of the 
questionnaire were modified accordingly. 24 To assess internal consistency (reliability) for 
insomnia and ESS, we measured Cronbach’s alpha for overall population and subgroups 
(age, gender and city).  Participants were asked about sleep duration (number of hours) 
during usual weekdays and weekends. The average duration of sleep per day was obtained 
by [(average of duration of sleep during weekdays * 6) + (average duration of sleep during 
weekends *1)]/7. Weekdays was multiplied by 6 because most establishments in South 
Asia have 6 working days a week. The average duration of sleep was categorized as <5, 5-
5.9, 6-6.9, 7-7.9, 8-8.9 and ≥ 9 hours.4  Participants were asked if they experience any of 
the following experiences of insomnia- “Have trouble falling asleep”; “Wake up during the 
night and have difficulty getting back to sleep” “Wake up too early in the morning and 
unable to get back to sleep”; and “Take sleeping pills or other medication to help you 
sleep” over past month.  Insomnia was categorized into ‘no’, ‘rare’, ‘occasional’ and 
‘frequent’ if the frequency of any insomnia was <2, 2-4, 5-15 and 16-30 nights/ month, 
respectively. If an individual had more than one symptom, insomnia was categorized 
based on the most frequent symptom.4 The Cronbach’s alpha for insomnia was 0.81, 
overall and varied between 0.78 and 0.85 for various subgroups.   
 
Participants were asked if they ever snored and if yes, how often they snored. They were 
coded as non-snorer if they either never snored or did not snore anymore, moderate 
snorer if they said rarely or sometimes (up to two nights per week) and habitual snorer if 
they answered frequently, almost always or always to the question.31 Regarding excessive 
daytime sleepiness (EDS), the Epworth Sleepiness Score (ESS) was used and categorized 
participant responses to chances (no chance=0; slight chance=1; moderate chance=2; high 
chance=3)  of  falling asleep in the following eight situations- sitting and reading; watching 
television; sitting inactive in a public place (such as a theatre or a meeting); riding as a 
passenger in a car for an hour without a break; lying down to rest in the afternoon when 
circumstances permit; sitting and talking to someone; sitting quietly after a lunch; in a car, 
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while stopped for a few minutes in traffic. The scores for all items were added together. A 
participant was coded as unlikely sleepy, average day time sleepiness, excessive sleepiness 
depending on the situation, and excessive sleepiness if the total score was 0-7, 8-9, 10-15 
and 16-24, respectively, based on ESS.29 There were only 50 participants with ESS 16-24, 
therefore this category was merged with ESS 10-15 and renamed EDS.  The Cronbach’s 
alpha for daytime sleepiness was 0.80, overall and varied between 0.78 and 0.85 for 
various subgroups.  
 
Regarding participant characteristics, self-reported age at baseline in completed years was 
used and categorized into three age groupings: 20-44, 45-59, and 60+ years.  Participant-
reported gender was used to code individuals as male or female. Self-reported highest 
education level attained was categorized into four categories - up to primary schooling; 
high or secondary schooling; up to university education; and university and higher. A 
wealth index based on different household amenities (separate cooking room and toilet 
facilities) and assets (television, refrigerator, washing machine, microwave, mixer-grinder, 
mobile phone, DVD player, computer, car, motor cycle, and bicycle) was used. Total scores 
were categorized into tertiles (lowest tertile representing poorest and highest tertile 
representing wealthiest).25 Self –reported current use of smoked tobacco (both cigarettes 
and bidis), history of heart disease and stroke was obtained from questionnaire. We used a 
modified food frequency questionnaire, to estimate average servings of fruits and 
vegetable intake per day and coded these into <2, 2-4 and ≥ 5 servings a day.  
 
Anthropometric parameters (height, weight, body composition, waist circumference, hip 
circumference, skin fold thickness) were measured using standard techniques either at 
participant’s home or at a temporary blood collection clinics organized closer to 
participant’s home. Measured height (meters) and weight (kilograms) was used to 
calculate body mass index (BMI) as weight / height2. A 15 ml fasting venous blood sample 
was collected for biochemical measurements. Fasting plasma glucose (FPG) was estimated 
using hexokinase/kinetic methods and total cholesterol (TC) estimated by enzymatic 
colorimetric cholesterol oxidase peroxidase.25,32  
 
Ethical issues: 
The CARRS Surveillance study was approved by the independent ethics committees of 
Public Health Foundation of India, All India Institute of Medical Sciences, New Delhi, 
Madras Diabetes Research Foundation, Chennai, India, Aga Khan University, Karachi, 
Pakistan, and Emory University, Atlanta, US. The CARRS Study obtained informed consent 
from all participants.  
 
Analysis:  
This analysis included 16,287 participants. The number of missing values in CARRS 
dataset has been published previously.25 In short, missing values in questionnaire data, 
blood pressure, BMI, blood biochemistry and overall were 0%, 4.9%, 23%, 15.8% and 
25%, respectively. To account for the missing variables, we used multiple imputation 
using chained equation (MICE) for imputing all missing values across all variables to 
create ten completed datasets. All covariates and the outcome were included in the 
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imputation model. Imputation methods are described in greater detail elsewhere.25 
Imputed values of missing continuous variables were modelled using linear regression 
and predictive mean matching, and imputed values of ordinal variables were modelled 
using ordinal logistic regression.  Model convergence was checked, and diagnostics were 
performed on the imputed dataset. Sample weighting was taken into account in the data 
analysis using stata command svyset, with a ‘ward’ variable as primary sampling unit. 
25,32,33 Standard weights and strata (6 strata of gender and age groups 20-44, 45-59, 60+ 
years) were used obtain weighted estimates. All analysis commands were prefixed with 
‘svy’ to obtain weighted percentages, means, coefficients or odds ratios, and 95% 
confidence intervals (CI). The distribution of sleep variables by city and gender were 
assessed as percentages with 95% CIs. 
 
We assessed collinearity between sleep variables by cross tabulation (results not shown) 
and found no significant collinearity between the sleep variables. For all regression 
analyses, 7-7.9 hours was used as the reference category for duration of sleep. We used 
logistic regression to model hypertension. Each sleep variable was modelled separately 
with hypertension to obtain unadjusted odds ratios (model-1). Individual sleep variables 
were then modelled adjusting for age as continuous variable and gender (model-2).  In 
model-3, we further adjusted for socio-demographic variables- education, wealth index 
and city.  In the model-4, we assessed for potential confounding by other variables (BMI, 
smoking, alcohol use, self-reported heart disease, stroke, family history of hypertension, 
fruits and vegetables intake, FPG and TC) using forward stepwise regression starting from 
the variables most strongly associated with hypertension in the bivariate analysis. Only 
BMI was found to confound the associations between sleep variable and BP categories, 
and therefore retained in model-4. Finally, we adjusted for other sleep variables in model-
5. We further assessed the interaction between sleep duration and insomnia categories, 
and between snoring and EDS on their effects on hypertension. We computed predicted 
probabilities and 95% confidence intervals (using robust standard errors) of hypertension 
for each of the sleep categories using model-5. We assessed interaction of age (20-44, 45-
59, ≥ 60 years), gender with sleep variables by introducing interaction term. We 
considered effect modification if the p-value of Wald test of interaction term was < 0.05. 
Further, we computed predicted probabilities and 95% confidence intervals (using robust 
standard errors) of hypertension for each of the sleep categories stratified by age and 
gender. BMI was one of the imputed variables, therefore stratification by BMI (which may 
vary between 10 imputed datasets) could have introduced bias. Hence, we were only able 
to assess effect modification of BMI by stratifying on BMI category (<18.5, 18.6-24.9, ≥ 
25kg/m2) for the non-missing complete cases.  In addition, we assessed the independent 
effect of separate symptoms of insomnia: initial (have trouble falling asleep); middle 
(wake up during the night and have difficulty getting back to sleep); late (wake up too 
early in the morning and be unable to get back to sleep) and medication for insomnia on 
hypertension using logistic regression adjusting for each other, other sleep factors, age, 
gender, education, wealth index, city and BMI. None of the logistic regression models were 
adjusted for hypertension medication.   
 
Further, we did two separate linear regressions with systolic and diastolic blood pressures 
as continuous outcome variables adjusting for medication for hypertension (model-1) and 
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adding age, gender, education, wealth index, city, BMI and other sleep variables (model-2) 
using multiple imputed dataset. Forty-three observations (0.26%) who reported not 
knowing their snoring patterns were dropped from the analysis in all the models.   
 
Finally, we performed a sensitivity analysis between the multiply imputed and complete 
case datasets. The weighted percentages (means, if continuous variable) of socio-
demographic variables, exposures, and hypertension; and adjusted estimates of logistic 
and linear regression models in both datasets were compared. We used Stata 14.2 for all 
statistical analyses. 
   
Results: 
The number of participants recruited from Chennai, Delhi and Karachi were 6906, 5364 
and 4017, respectively.  Mean (standard deviation [SD]) age of participants total and city 
wise (Chennai, Delhi and Karachi) were 42.3 (12.6), 41.7 (12.2), 44.1 (12.2) and 41.7 
(13.9) years, respectively.   
Women constituted 52.4%, 53.9 %, 49.9 %, and 52.9% in overall, Chennai, Delhi and 
Karachi, respectively.  The mean (SD) years of schooling in all, Chennai, Delhi and Karachi 
were 8.0 (5.0), 7.5 (4.2), 8.7 (5.4) and 7.1 (5.3), respectively. The complete description of 
CARRS population has been published previously.25 
 
Table-1 shows the distribution of duration of sleep and sleep disturbances in the study 
population by gender and city.  Overall, 5.5% and 1.9% of participants slept <5 and 5-6 
hours, respectively. This distribution varied by city, with Chennai having lowest 
prevalence of short sleep and Karachi the highest. About 12.4% of participants slept 
greater than 9 hours on average. This again varied by city, with Delhi having lowest 
prevalence of long sleepers and Karachi the highest. The mean (SD) duration of sleep was 
7.3 (1.2) hours in total population which was longest in Chennai women (7.7 [1.1] hours) 
and shortest in Delhi men (6.9 [1.1] hours). With respect to insomnia, about 12% of 
participants reported insomnia: either rare, occasional, or frequent. Women reported 
higher prevalence of insomnia than men in all three cities; the difference between genders 
was particularly striking in Karachi. Moderate and habitual snoring was reported by 
14.5% and 14.2% of participants, overall. Snoring was more common among men than 
women overall. However, in Karachi, habitual snoring was more common among women 
compared to men. EDS was the least common sleep problem in these South Asian cities 
with 2.8% and 1.8% reporting average and excessive daytime sleepiness respectively. EDS 
was lowest in Chennai and highest in Karachi.  
  
Table-2 presents the results of logistic regression analyses examining the relationships of 
sleep variables with hypertension. In unadjusted logistic regression (model-1), the odds of 
hypertension were higher with shorter duration of sleep and lower with longer duration 
of sleep when compared to 7-8 hours of sleep. However, this relationship did not hold 
after adjustment for sociodemographic variables and the fully adjusted model-5 showed 
no relationship between sleep duration and hypertension.  Participants with rare 
occasional and frequent insomnia had significantly higher odds of hypertension compared 
to those with no insomnia. The effect size was slightly attenuated after adjusting for age 
and sex but remained significant. The magnitudes of these associations were unchanged in 
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the remaining adjusted models.  The adjusted odds ratio of hypertension for early, middle, 
late and medication for insomnia were 1.09 (0.85, 1.39), 1.44 (1.06, 1.96). 0.87 (0.64, 1.20) 
and 1.85 (1.33, 2.59), respectively. (not in the table)  
Both moderate snorers and habitual snorers had significantly higher odds of hypertension 
compared to non-snorers in model-1. However, the strength of this association was 
attenuated after adjusting for age and gender in model-2 and BMI in model -4. Adjusting 
for other sleep variables had no further substantial impact on the magnitude of 
associations (model-5). When assessing for patterns of relationships across snoring 
categories, there were significant associations between snoring categories and 
hypertension (Wald test p-value< 0.001 [data not shown]). In unadjusted models, the odds 
of hypertension were significantly higher if the participant had EDS; however, this 
association no longer existed after adjusting for age and sex in model-2, and remained 
non-significant in all further models (table-2).  
 
Table-3 presents that association of sleep variables and hypertension, stratified by age 
groups. The associations between snoring and hypertension were more pronounced in 
young participants (20-44 years) and there was no association in the oldest group (≥ 60 
years). There was a significant interaction between sleep duration and age groups.  The 
odds ratio of hypertension was significantly higher among young adults who slept 6-6.9 
hours but no significant association in other age groups. Additionally, associations 
between insomnia and hypertension were stronger in in middle and older age groups 
implying a significant interaction between age group and insomnia. And, the snoring and 
hypertension association were stronger in younger age groups (table-3). The association 
of sleep variables and hypertension were similar in both genders (table-4). We found no 
effect modification of BMI on sleep variables and hypertension relationship in the 
complete case analysis (supplementary table-3). We also found no significant interaction 
by insomnia for sleep duration and hypertension, nor by snoring for EDS and 
hypertension (data not shown).  
 
In analyses using continuous SBP and DBP as outcomes, moderate and habitual snoring 
were significantly associated with higher SBP and DBP, even after adjusting for 
hypertension treatment. The associations were highly attenuated but remained significant 
after adjusting for other variables. We found no relationships between duration of sleep, 
insomnia, and EDS with either systolic or diastolic blood pressure (table-5).  
 
In sensitivity analyses, we found that the complete case and MI datasets did not differ in 
any of the demographic, socio economic, behavioral, exposure, or outcome parameters 
(see supplementary table-1).  The estimates from logistic and linear regressions were 
comparable between two datasets (see supplementary table-2).  
 
 
Discussion:  
In this representative adult population from three mega cities of South Asia, nearly a third 
of the population had either moderate or habitual snoring but only about 5% had daytime 
sleepiness. The percentage of adults sleeping longer than optimum hours were much 
higher than shorter duration of sleep. The principal findings in this large study of sleep 
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and hypertension in South Asia was that self-reported snoring was associated with 
hypertension among urban adults. This association was independent of prominent risk 
factors for hypertension. Further, we noted significant associations across snoring 
categories with hypertension and linear associations with blood pressure. The 
associations were stronger in younger individuals and women.   
 
The current study estimates are similar to the findings from a large cross-sectional study 
of 10413 adults (50-85 years) from Guangzhou in China, where daily snorers had higher 
odds of hypertension 1.37 (1.20-1.56)  compared to non-snorers.34 Similarly, a 10-year 
follow up study of 2451 Swedish men showed persistent snoring was independently 
associated with incident hypertension after adjusting for other risk factors among younger 
men (30-49 years at baseline) but not among older men (50-69 years at baseline).16 
However, in a population based survey of 6779 Swedish women, snoring was associated 
with hypertension only in presence of daytime sleepiness15 while a smaller study among 
Hispanics Americans found no association between snoring and hypertension.35 This 
indicates that there may be heterogeneity in snoring and hypertension relationships 
across populations. Nevertheless, a meta-analysis of longitudinal studies has confirmed 
that snoring is a risk factor for hypertension.10  
 
While the direction of associations cannot be established in this cross-sectional study, the 
coexistence of snoring and hypertension has clinical implications. Although snoring is a 
symptom of OSA,13 not all snorers may have OSA. Indeed, the relationships between 
snoring and cardio-metabolic disorders could be independent of OSA.16 The relationships 
between OSA and hypertension may also be bidirectional 14. Untreated coexistence of OSA 
may lead to uncontrolled hypertension despite medical treatment for hypertension.36 
Conversely, treatment of hypertension to a lower BP target may improve sleep apnea by 
improving upper airway tone.14 Therefore, screening for snoring and OSA, and 
appropriate treatment among people with hypertension specifically among young adults 
and vice versa may help control  both conditions.  
 
The percentage of people reporting EDS in South Asian adults was small (4%). A smaller 
study from Chennai20 which used snoring, tiredness during daytime, observed apnea, and 
high blood pressure (STOP) questionnaire37  found 59% of adults had daytime sleepiness.  
However, the ESS instrument used in our study is more robust measure as it uses a 
comprehensive score and also was found to have higher specificity and positive predictive 
values compared to STOP.38 We found no associations between EDS and hypertension in 
South Asian cities. This is unsurprising as previous studies showed EDS was associated 
with hypertension only in persons with OSA.8  
 
The present analysis found that having insomnia, irrespective of the frequency was 
associated with about 40% higher odds of hypertension. These results contrast with  a 
cross-sectional analysis of symptoms of insomnia and hypertension in 12,643 adults from 
the US’ National Health And Nutrition Examinations Surveys (NHANES) which found no 
such association.11 However, our findings are consistent with a meta-analysis of 
prospective studies that showed insomnia was positively associated with hypertension.10 
Another study from Finland, following employees with insomnia assessed during baseline 
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found that odds of the use of antihypertensive medication  was higher by 40% and 47% 
among persons with occasional and frequent insomnia respectively at the baseline39.   The 
definition of frequent insomnia as defined in our study is in line with definition of 
insomnia disorder i.e. insomnia symptoms for at least three days a week. 9  We found the 
odds of hypertension in this group was similar to odds for rare or occasional insomnia.  
But, among the individual symptoms of insomnia, only medication used for insomnia 
remained significantly associated with hypertension indicating higher hypertension in 
severe insomnia.  Disruptions in hypothamic-pituitary-adrenal axis and circadian 
rhythmicity, 40 sympathetic activation,  oxidative stress, systemic inflammation and 
hypoxemia40,41 are possible mechanisms on how insomnia might be related to elevated 
blood pressure. The cross-sectional analysis and lack of dose-response relationship makes 
it difficult to say definitively and to investigate the root causes of the relationships 
between insomnia and hypertension in our analysis.  
 
We found no association between either short or long duration of sleep with hypertension 
after adjusting for other hypertension risk factors among South Asian adults. The Sleep 
Heart Health Study from the US, suggested a ‘‘U” shaped relationship between duration of 
sleep and hypertension.4 However, there is huge variation in duration of sleep and 
hypertension relationships by gender,42 age groups,43,44 and geographical regions.2  
Further exploration of the social context of sleep loss and the role of stress and other 
psychological factors in its occurrence may help explain these study and regional 
differences. Indeed, more open-ended and qualitative perspectives may be helpful in 
seeking the underlying causes of poor sleep patterns.   
 
This study has several limitations that should be considered. First, this was a cross 
sectional study and therefore directions of association between sleep variables and 
snoring cannot be ascertained and  there is a potential for reverse causality.10 Second, self-
reported sleep variables, specifically snoring, are subject to recall and information bias, 
and probably best asked of the participant’s partner. Validation of sleep questions against 
roommate/partner’s report in the United States found moderate to high correlation,45 
however no such validation studies exists in India, where cultural norms may influence 
participant responses differently to the USA.  Nevertheless, any measurement error in 
exposure variables is likely to be non-differential (unlikely to be affected by hypertension 
status). If anything, this would possibly had pulled the associations towards the null and 
therefore the true relationships may have been underestimated rather than 
overestimated. Additionally, due to lack of objective measurements, it was not possible to 
differentiate between primary or simple snoring and snoring as marker of obstructive 
sleep apnea. 46 Third, the models were not adjusted for time of blood pressure 
measurement.  Since time of blood pressure measurement varied between participants 
(between 7 AM to 4 PM), this may have non-differentially affected the sleep- blood 
pressure relationship.  In future, ambulatory blood pressure measurements may be useful 
to further explain this relationship. Finally, the analysis was not adjusted for many other 
potential confounders such as physical activity, depression, and intake of caffeine or 
medications that are associated with poor sleep such as aspirin, non-steroidal anti-
inflammatory drugs, and hormones. There may also be residual confounding by these 
variables which may have distorted the study results. However, the analysis was adjusted 
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for the variables commonly included in publications examining associations between sleep 
and hypertension, and the associations reported above remained after adjustment for 
these variables. 
 
The study also has several strengths. This was first study in South Asia reporting on the 
association between sleep factors and hypertension using large representative 
populations of three mega cities with such a high response rate. Secondly, the study used 
standardized protocol across all sites with stringent quality assurance and quality control. 
Thirdly, blood pressure, BMI, and biochemistry were all objectively measured. Fourth, the 
study reported on association between sleep variables with both hypertension and 
continuous measures of BP. Finally, we considered a large variety of potential confounders 
in order to minimize residual confounding.   
 
Conclusion: 
Moderate and habitual snoring was highly prevalent and was positively associated with 
hypertension, specifically in young adults and women in South Asian metropolitan cities.  
Any level of insomnia was also associated with higher odds of hypertension. Duration of 
sleep and daytime sleepiness were not associated with hypertension. Association of sleep 
variables with hypertension in this population needs further exploration through robust 
longitudinal studies in this region.   
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Table-1: Distribution of sleep variables by gender and city (N=16287) 
Sleep 
Variables  
All   Chennai Delhi Karachi  
Total Men Women Men Women Men Women Men Women 
Numbers*  16287 7760 8527 3188 3788 2680 2684 1892 2125 
Duration of Sleep (hours)   
<5  5.5 [5.0, 6.0] 5.2 (4.5, 5.9) 5.8 (5.0, 6.5) 3.0 (2.2, 3.9) 2.2 (1.5, 2.8) 5.1 (3.9, 6.2) 6.2 (5.0, 7.4) 8.8 (7.3, 10.3) 11.4 (9.2, 13.7) 
5-5.9 1.9 (1.6, 2.2) 1.8 (1.3, 2.2) 2.0 (1.6, 2.5) 0.8 (0.3, 1.4) 0.6 (0.2, 1.0) 2.5 (1.6, 3.3) 2.6 (1.9, 3.3) 2.3 (1.8, 2.8) 3.8 (3.0, 4.6) 
6-6.9 21.1 (19.9, 22.3) 23.0 (21.2, 24.7) 19.4 (17.7, 21.1) 14.4 (12.2, 16.6) 11.4 (9.7, 13.2) 30.4 (27.8, 33.0) 24.6 (22.4, 26.8) 26.7 (24.5, 28.8) 26.5 (24.6, 28.5) 
7-7.9 28.4 (27.3, 29.4) 27.9 (26.6, 29.2) 28.8 (27.2, 30.3) 24.7 (22.6, 26.8) 27.5 (25.5, 29.5) 35.9 (33.8, 38.0) 35.1 (32.4, 37.7) 21.8 (20.1, 23.5) 23.1 (20.7, 25.4) 
8-8.9 30.8 (29.0 ,32.6) 31.3 (29.3, 33.3) 30.3 (27.5, 33.2) 41.4 (38.5, 44.4) 41.4 (38.8, 44.1) 20.9 (18.7, 23.0) 26.3 (23.2, 29.4) 29.4 (27.7, 31.1) 16.3 (14.1, 18.5) 
  ≥9 12.4 (11.4, 13.4) 10.9 (9.6, 12.2) 13.7 (12.3, 15.1) 15.6 (13.4, 17.8) 16.9 (14.4, 19.4) 5.3 (4.0, 6.7) 5.2 (4.1, 6.4) 11.1 (9.5, 12.6) 18.9 (17.0, 20.7) 
Mean (SD)  7.3 (1.2)  7.2 (1.2) 7.3 (1.2) 7.6 (1.1) 7.7 (1.1) 6.9 (1.1) 7.0 (1.1) 7.1 (1.2) 7.1 (1.2) 
Insomnia (nights/month) 
No 86.5 (85.2, 87.8) 91.2 (90.4, 92.1) 82.2 (80.2, 84.1) 91.5 (90.3, 92.8) 89.0 (87.4, 90.5) 94.3 (93.2, 95.5) 83.7 (81.4, 86.0) 86.4 (84.5, 88.2) 68.4 (65.6, 71.2) 
Rare 4.9 (4.4, 5.4) 3.0 (2.6, 3.5) 6.6 (5.8, 7.3) 3.3 (2.5, 4.1) 4.9 (3.8, 5.9) 2.0 (1.4, 2.7) 8.5 (7.2, 9.7) 4.1 (3.1, 5.1) 7.1 (5.7, 8.5) 
Occasional 4.7(4.0, 5.4) 3.1 (2.5, 3.6) 6.1 (5.0, 7.3) 2.0 (1.3, 2.7) 2.2 (1.6, 2.8) 2.1 (1.5, 2.8) 4.1 (3.1, 5.2) 6.1 (4.9, 7.2) 15.5 (13.5, 17.6) 
Frequent 4.0 (3.5, 4.4) 2.6 (2.2 ,3.1) 5.1 (4.5, 5.8) 3.2 (2.5, 3.8) 4.0 (3.1, 4.9) 1.5 (1.0, 2.1) 3.7 (2.9, 4.4) 3.4 (2.6, 4.2) 9.0 (7.4, 10.5) 
Snoring frequency 
Non-snorer 71.0 (69.8, 72.3) 65.2 (63.3, 67.1) 76.4 (74.8, 77.9) 67.0 (64.3, 69.7) 83.1 (81.5, 84.7) 55.5 (52.0, 59.1) 67.2 (64.3, 70.1) 75.8 (72.6, 79.1) 76.3 (72.7, 79.8) 
Moderate 
snorer 
14.5 (13.7, 15.3) 17.9 (16.6, 19.1) 11.5 (10.6, 12.4) 20.0 (18.2, 21.9) 9.6 (8.3, 10.9) 18.3 (16.1, 20.4) 15.1 (13.0, 17.1) 13.7 (11.9, 15.4) 10.4 (8.9, 12.0) 
Habitual 
snorer 
14.2 (13.3, 15.1) 16.7 (15.3, 18.1) 11.9 (10.8, 13.0  12.4 (10.3, 14.5) 6.9 (5.8, 8.0) 26.1 (23.6, 28.7) 17.6 (15.7, 19.5) 10.4 (8.4, 12.5) 13.3 (10.8, 15.8) 
Don't know 0.2 (0.1, 0.3) 0.3 (0.1, 0.4) 0.2 (0.1, 0.4) 0.6 (0.2, 0.9) 0.3 (0.1, 0.6) 0.0(0.0, 0.1) 0.2 (0.0, 0.4) 0.0 (0.0, 0.1) 0.1 (-0.1, 0.2) 
Daytime sleepiness  
Unlikely  95.4 (94.9, 96.0) 96.1 (95.4, 96.8) 94.9 (94.0, 95.7) 98.2 (97.4, 99.1) 98.6 (97.9, 99.3) 95.7 (94.7, 96.7) 87.8 (85.9, 89.8) 93.0 (91.6, 94.4) 97.2 (96.3, 98.1) 
Average   2.8 (2.4, 3.2) 2.2 (1.7, 2.6) 3.4 (2.7, 4.0) 0.9 (0.5, 1.4) 1.1 (0.4, 1.8) 2.2 (1.5, 2.9) 8.0 (6.2, 9.8) 4.1 (3.2, 5.0) 1.4 (1.0, 1.9) 
Excessive^ 1.8 (1.5, 2.1) 1.8 (1.4, 2.2) 1.8 (1.3, 2.3) 0.8 (0.2, 1.4) 0.3 (0.1, 0.4) 2.1 (1.3, 2.9) 4.2 (3.0, 5.4) 2.9 (2.2, 3.7) 1.4 (0.7, 2.1) 
Notes: Estimates are in percentage and 95% confidence interval unless specified; *raw numbers; ^Excessive daytime sleepiness was defined as Epworth Sleepiness Score ≥ 
10 because group ≥ 15   had only 50 observations and therefore was merged with 10-15 group 
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Table 2: Logistic regression models of association between sleep variables and hypertension (N=16244*) 
 
Sleep variables  
Odds ratios (95% CI) Predicted 
probability of 
hypertension 
from model- 5# 
% (95%CI) 
Model-1 
(Crude) 
Model-2 
age and sex 
adjusted 
Model-3 
(model-2+ 
education, wealth 
index and city) 
Model-4 
(model-3+ BMI) 
Model-5 
(model- 4+ 
sleep variables) 
Duration of Sleep (hours)            
<5  1.35 (1.15, 1.60) 1.03 (0.87, 1.22) 1.05 (0.88, 1.25) 1.07 (0.89, 1.28) 0.99 (0.82, 1.19) 29.9 (26.8, 33.0) 
5-5.9 1.13 (0.86, 1.49) 1.12 (0.84, 1.50) 1.07 (0.80, 1.43) 1.08 (0.81, 1.45) 1.00 (0.74, 1.35) 30.1(24.7, 35.4) 
6-6.9 1.10 (0.98, 1.23) 0.98 (0.87, 1.11) 0.97 (0.86, 1.10) 0.98 (0.86, 1.10) 0.97 (0.86, 1.10) 29.5 (27.9, 31.2) 
7-7.9 reference 30.0 (28.4, 31.7) 
8-8.9 0.90 (0.79, 1.01) 0.92 (0.81, 1.04) 0.99 (0.87, 1.13) 0.99 (0.87, 1.14) 1.01 (0.89, 1.16) 30.3 (28.4, 32.1) 
  ≥9 0.79 (0.67, 0.94) 0.88 (0.75, 1.04) 0.99 (0.84, 1.16) 1.02 (0.86, 1.20) 1.02 (0.86, 1.21) 30.4 (27.7, 33.2) 
Insomnia (nights/month)           
No  reference  29.2 (28.1, 30.4) 
Rare 1.58 (1.29, 1.95) 1.46 (1.18, 1.80) 1.44 (1.17, 1.78) 1.41 (1.13, 1.77) 1.41 (1.12, 1.77) 35.5 (31.3, 39.6) 
Occasional  1.61 (1.36, 1.91) 1.41 (1.20, 1.66) 1.44 (1.21, 1.70) 1.43 (1.20, 1.70) 1.39 (1.16, 1.67) 35.2 (31.8, 38.6) 
Frequent  1.61 (1.30, 1.99) 1.3(1.06, 1.60) 1.38 (1.13, 1.68) 1.36 (1.10, 1.67) 1.34 (1.09, 1.65) 34.5 (30.5, 38.5) 
Snoring frequency           
Non-snorer reference  28.4 (27.2, 29.6) 
Moderate snorer  1.81 (1.62, 2.02) 1.48 (1.31, 1.66) 1.43 (1.27, 1.60) 1.18 (1.05, 1.34) 1.18 (1.04, 1.33) 31.3 (29.2, 33.5) 
Habitual snorer  2.72 (2.42, 3.05) 2.03 (1.80, 2.29) 1.87 (1.65, 2.12) 1.49 (1.31, 1.69) 1.47 (1.29, 1.67) 35.4 (33.2, 37.7) 
Daytime sleepiness            
Unlikely  reference  30.1 (29.0, 31.2) 
Average   1.21 (0.96, 1.53) 1.09 (0.85, 1.39) 0.97 (0.76, 1.23) 0.92 (0.72, 1.17) 0.91 (0.71, 1.16) 28.4 (24.3, 32.5) 
Excessive 1.39 (1.07, 1.82) 1.15 (0.86, 1.52) 1.06 (0.79, 1.41) 1.02 (0.75, 1.38) 0.92 (0.68, 1.25) 28.7 (23.5, 33.8) 
Notes: * Raw numbers, N= 16,244 as 43 observations who reported “don't know” for snoring were dropped from the analysis; # covariates used- age, gender, city, education, 
wealth index, body mass index and other sleep variables  
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Table-3: Logistic regression models$ of association between sleep variables and hypertension stratified by age group (N=16244*) 
 
  Adjusted odds ratios (95% CI) 
$ Predicted probabilities of hypertension % (95% CI) # 
Sleep Characteristics 20-44 years 45-59 years ≥ 60 years p-value^ 20-44 years 45-59 years ≥ 60 years 
Duration of Sleep (hours)   
<5  0.99 (0.75, 1.32) 1.10 (0.83 ,1.46) 0.65 (0.40, 1.08) 
0.0135 
19.9 (15.7, 24.1) 48.1 (42.1, 54.1) 54.0 (43.4, 64.7) 
5-5.9 1.46 (1.03, 2.09) 0.66 (0.43, 1.03) 0.31 (0.12, 0.80) 26.3 (19.6, 33.0) 36.7 (27.3, 46.0) 36.8 (16.5, 57.2) 
6-6.9 0.96 (0.81, 1.14) 1.03 (0.85, 1.24) 0.92 (0.61, 1.38) 19.4 (17.5, 21.3) 46.5 (43.1, 50.0) 61.8 (54.5, 69.1) 
7-7.9 reference  20.0 (17.9, 22.2) 45.8 (43.1, 48.6) 63.6 (57.4, 69.8) 
8-8.9 0.98 (0.81, 1.18) 1.01 (0.84, 1.21) 1.02 (0.69, 1.50) 19.7 (17.6, 21.8) 46.0 (42.7, 49.4) 64.0 (57.6, 70.5) 
  ≥9 0.85 (0.67, 1.08) 1.11 (0.83, 1.48) 1.38 (0.83, 2.31) 17.7 (14.7, 20.8) 48.3 (42.2, 54.4) 70.3 (62.0, 78.6) 
Insomnia (nights/month)  
No  reference  
0.0071 
19.3 (17.9, 20.7) 44.2 (42.3, 46.1) 61.3 (56.7, 65.8) 
Rare 1.34 (0.94, 1.92) 1.59 (1.16, 2.18) 1.67 (0.92, 3.06) 23.9 (18.4, 29.5) 55.0 (47.8, 62.3) 72.0 (61.5, 82.5) 
Occasional  1.20 (0.92, 1.56) 1.58 (1.19, 2.09) 2.37 (1.20, 4.71) 22.1 (17.9, 26.2) 54.9 (48.6, 61.2) 78.2 (67.5, 89.0) 
Frequent  1.11 (0.80, 1.54) 2.05 (1.53, 2.74) 0.74 (0.38, 1.41) 20.8 (15.7, 25.9) 60.8 (54.2, 67.5) 54.3 (40.8, 67.8) 
Snoring frequency 
Non-snorer reference  
0.0021 
17.6 (16.2, 19.0) 44.6 (42.4, 46.8) 63.6 (59.5, 67.6) 
Moderate snorer  1.44 (1.21, 1.71) 1.08 (0.90, 1.30) 0.76 (0.49, 1.18) 23.2 (20.2, 26.2) 46.5 (42.9, 50.1) 57.4 (47.7, 67.2) 
Habitual snorer  1.87 (1.56, 2.24) 1.30 (1.09, 1.54) 1.16 (0.77, 1.74) 28.0 (24.9, 31.0) 50.7 (46.8, 54.6) 66.7 (58.7, 74.6) 
Daytime sleepiness  
Unlikely  reference  
0.865 
19.7 (18.3, 21.0) 46.3 (44.5, 48.1) 63.1(59.4, 66.8) 
Average   0.84 (0.54, 1.31) 1.05 (0.77, 1.43) 0.85 (0.43, 1.68) 17.3 (11.2, 23.3) 47.4 (40.4, 54.4) 59.5 (44.5, 74.4) 
Excessive 1.04 (0.64, 1.70) 0.86 (0.56, 1.30) 1.02 (0.39, 2.66) 20.3 (13.3, 27.4) 42.7 (33.0, 52.5) 63.6 (42.0, 85.1) 
Notes: * Raw numbers, N= 16,244 as 43 observations who reported “don't know” for snoring were dropped from the analysis; $ all models adjusted for age, sex, city, wealth 
index, education, body mass index and other sleep variables; ^ Wald test for effect modification of age group; 
# 
covariates used- age, gender, city, education, wealth index, 
body mass index and other sleep variables  
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Table-4: Logistic regression models$ of association between sleep variables and hypertension stratified by gender (N=16244*) 
 
Sleep Characteristics 
Adjusted odds ratios (95% CI)  
Predicted probabilities of hypertension 
% (95% CI) # 
Men Women p-value^ Men Women  
Duration of Sleep (hours)   
<5  0.94 (0.71, 1.24) 1.06 (0.83, 1.34) 
0.9277 
32.6 (27.6, 37.6) 27.6 (23.8, 31.4) 
5-5.9 0.97 (0.61, 1.55) 1.03 (0.70, 1.51) 33.2 (23.8, 42.6) 27.2 (21.1, 33.2) 
6-6.9 0.98 (0.84, 1.15) 0.97 (0.80, 1.16) 33.4 (31.1, 35.7) 26.1 (23.8, 28.4) 
7-7.9 reference  33.7 (31.0, 36.5) 26.7 (24.6, 28.7) 
8-8.9 0.99 (0.83, 1.16) 1.04 (0.84, 1.29) 33.5 (30.9, 36.0) 27.4 (24.8, 30.0) 
  ≥9 0.95 (0.74, 1.22) 1.09 (0.86, 1.37) 32.7 (28.5, 36.9) 28.0 (24.4, 31.7) 
Insomnia (nights/month) 
No  reference  
0.4649 
33.1 (31.3, 35.0) 25.7 (24.4, 27.0) 
Rare 1.19 (0.84 ,1.67) 1.52 (1.13, 2.04) 36.3 (30.1, 42.6) 32.9 (27.8, 38.1) 
Occasional  1.23 (0.89, 1.70) 1.50 (1.20, 1.87) 37.1 (31.0, 43.2) 32.7 (28.8, 36.7) 
Frequent  1.17 (0.82, 1.67) 1.44 (1.11, 1.86) 36.0 (29.0, 43.1) 32.0 (27.2, 36.7) 
Snoring frequency 
Non-snorer reference  
0.2090 
31.9 (30.0, 33.8) 25.4 (23.9, 26.8) 
Moderate snorer  1.07 (0.91, 1.25) 1.33 (1.10, 1.61) 33.1 (29.9, 36.3) 30.3 (27.3, 33.2) 
Habitual snorer  1.43 (1.19, 1.71) 1.50 (1.27, 1.78) 38.8 (35.4, 42.1) 32.4 (29.4, 35.4) 
Daytime sleepiness  
Unlikely  reference  
0.1500 
33.5 (31.8, 35.3) 27.0 (25.7, 28.3) 
Average   0.97 (0.67,1.39) 0.86 (0.61, 1.21) 32.9 (25.9, 40.0) 24.6 (19.5, 29.7) 
Excessive 0.68 (0.42,1.10) 1.22 (0.83, 1.81) 26.8 (18.9, 34.8) 30.5 (23.7, 37.2) 
Notes: Estimates are in in odds ratio (95% confidence interval); $ all models adjusted for age, sex, city, wealth index, education, body mass index and other sleep variables; * Raw 
numbers, N= 16,244 as 43 observations who reported “don't know” for snoring were dropped from the analysis; ^ Wald test for effect modification of gender; 
# 
covariates used- 
age, gender, city, education, wealth index, body mass index and other sleep variables  
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Table 5:  Linear regression models of association between sleep variables with systolic and diastolic blood pressures (N=16244*) 
Sleep 
Characteristics 
Systolic blood pressure  
(mm Hg (95%CI)) 
Diastolic blood pressure  
(mm Hg (95%CI)) 
Model 1$ Model 2@ Model 1$ Model 2@ 
Duration of Sleep (hours)   
<5  0.84 (-0.76, 2.44) -0.30 (-1.77, 0.16) -0.46 (-1.45, 0.54) -0.52 (-1.45, 0.42) 
5-5.9 -0.94 (-3.30, 1.43) -0.68 (-2.72, 1.36) 0.07 (-1.39, 1.52) 0.14 (-1.24, 1.53) 
6-6.9 0.94 (-0.02, 1.90) -0.01 (-0.89, 0.87) 0.22 (-0.39, 0.83) -0.09 (-0.66, 0.49) 
7-7.9 reference  
8-8.9 -0.40 (-1.39, 0.59) 0.51 (-0.32, 1.34) -0.55 (-1.18, 0.09) 0.00 (-0.57, 0.57) 
  ≥9 -2.15 (-3.43, -0.86) 0.69 (-0.33, 1.71) -1.65 (-2.42, -0.88) -0.13 (-0.81, 0.54) 
Insomnia (nights/month) 
No  reference  
Rare -0.77 (-2.50, 0.95) -0.50 (-2.15, 1.16) -0.03 (-1.05, 0.99) 0.10 (-0.91, 1.12) 
Occasional  -0.71 (-2.63, 1.21) 0.38 (-1.41, 2.16) -0.45 (-1.58, 0.67) 0.35 (-0.76, 1.46) 
Frequent  0.48 (-1.36, 2.31) 0.56 (-1.12, 2.25) 0.05 (-1.14, 1.24) 0.47 (-0.68, 1.62) 
Snoring frequency 
Non-snorer reference  
Moderate snorer  5.21 (4.21,6.21) 1.04 (0.08, 2.00) 3.78 (3.18, 4.38) 1.39 (0.78, 1.99) 
Habitual snorer  7.90 (6.74,9.06) 2.34 (1.31, 3.36) 5.14 (4.49, 5.79) 1.97 (1.31, 2.62) 
Daytime sleepiness  
Unlikely  reference  
Average   1.18 (-0.72, 3.08) -0.49 (-2.27, 1.30) 1.00 (-0.23, 2.24) -0.14 (-1.38, 1.10) 
Excessive 2.16 (-0.26, 4.58) -0.34 (-2.46, 1.78) 0.98 (-0.48, 2.44) -0.31 (-1.70, 1.08) 
Notes: Estimates are blood pressure in mm Hg; *Raw numbers, 16,244 as 43 observations who reported “don't know” for snoring were dropped from the analysis; SBP- 
Systolic Blood Pressure; DBP: Diastolic Blood Pressure; $Model 1: Adjusted for hypertension treatment; @Model 2:  adjusted for hypertension treatment, age, sex, city, 
wealth index, education, body mass index and other sleep variables  
